Skip to main content
. 2022 Jan 24;27:100299. doi: 10.1016/j.jctube.2022.100299

Fig. 4.

Fig. 4

Number of secondary transmissions per case for 93 selected R3clone isolates grouped by tuberculosis (TB) treatment history. Cat 1: patients diagnosed with rifampicin-resistant TB after failure or relapse to category 1 anti-TB treatment; Cat 2: patients diagnosed with rifampicin-resistant TB after failure or relapse to category 2 anti-TB treatment.